Efficacy of Implantable Cardioverter-defibrillators for Secondary Prevention of Sudden Cardiac Death in Patients with End-stage Renal Disease

End-stage renal disease (ESRD) constitutes a major burden on the health-care system in the United States, with more than 300,000 patients nationwide being treated with renal replacement therapy. Very few studies to date have evaluated the benefit of implantable cardioverter-defibrillator (ICD) impla...

Descripción completa

Detalles Bibliográficos
Autores principales: Payne, Taylor, Waller, Jennifer, Kheda, Mufaddal, Nahman, N. Stanley, Maalouf, Joyce, Gopal, Aaron, Hreibe, Haitham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MediaSphere Medical 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452739/
https://www.ncbi.nlm.nih.gov/pubmed/32874746
http://dx.doi.org/10.19102/icrm.2020.110803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452739/
https://www.ncbi.nlm.nih.gov/pubmed/32874746
http://dx.doi.org/10.19102/icrm.2020.110803

Ejemplares similares